Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Role of Iscomatrix Bilayer Composition to Induce a Cell Mediated Immunity and Protection Against Leishmaniasis in Balb/C Mice



Mehravaran A1 ; Jaafari MR2 ; Jalali SA3 ; Khamesipour A4 ; Ranjbar R5 ; Hojatizade M1 ; Badiee A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Scienceas, Mashhad, Iran
  2. 2. Biotechnology Research Center, Nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
  3. 3. Immunology Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Molecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

Source: Iranian Journal of Basic Medical Sciences Published:2016

Abstract

Objective(s): Development of new generation of vaccines against leishmaniasis is possible because long-term protection is usually seen after recovery from cutaneous leishmaniasis. ISCOMATRIX is particulate antigen delivery system composed of antigen, cholesterol, phospholipid and saponin. In this study, the role of ISCOMATRIX bilayer composition made by different phase transition temperature (Tc) to induce a type of immune response and protection against leishmaniasis was assessed. Materials and Methods: ISCOMATRIX formulations with different bilayer compositions consisting of EPC (Tc <0 °C), DMPC (Tc 23 °C) and DSPC (Tc 54 °C) were prepared. Different ISCOMATRIX formulations were mixed with soluble Leishmania antigens (SLA). BALB/c mice were immunized subcutaneously, three times with 2-week intervals. As criteria for protection, footpads swelling, parasite burden, determination of IgG isotypes and the level of IFN-γ and IL-4 were assessed. Results: Although the groups of mice immunized with ISCOMATRIX DMPC or ISCOMATRIX DSPC showed the smallest footpad swelling and least parasite burden compared with the buffer group, the difference was not significant. Moreover, the highest level of IFN-γ and IL-4 was observed in the splenocytes of mice immunized with ISCOMATRIX DMPC or ISCOMATRIX DSPC, respectively. After challenge, the mice immunized with ISCOMATRIX DSPC showed the highest elevation of IgG, IgG1 and IgG2a antibodies (P<0.01) compared with control group. However, our results indicated that ISCOMATRIX EPC, DMPC or DSPC generated a mixed Th1/Th2 response that was not protective. Conclusion: Our results showed that the adjuvanticity of prepared ISCOMATRIX doesn’t influence with different phospholipids at least in our mice model. © 2016, Mashhad University of Medical Sciences. All right reserved.
Related Docs
View other Related Docs
1. Cationic Immune Stimulating Complexes Containing Soluble Leishmania Antigens: Preparation, Characterization and in Vivo Immune Response Evaluation, Iranian Journal of Immunology (2015)
2. The Role of Lpd-Nanoparticles Containing Recombinant Major Surface Glycoprotein of Leishmania (Rgp63) in Protection Against Leishmaniasis in Murine Model, Immunopharmacology and Immunotoxicology (2018)
3. Coadminstration of L. Major Amastigote Class I Nuclease (Rlmacin) With Lpd Nanoparticles Delays the Progression of Skin Lesion and the L. Major Dissemination to the Spleen in Balb/C Mice-Based Experimental Setting, Acta Tropica (2016)
4. Pegylation of Cationic Liposomes Encapsulating Soluble Leishmania Antigens Reduces the Adjuvant Efficacy of Liposomes in Murine Model, Parasite Immunology (2017)
5. Delivery Systems for Leishmania Vaccine Development, Expert Review of Vaccines (2016)
6. Cationic Liposomes Formulated With a Novel Whole Leishmania Lysate (Wll) As a Vaccine for Leishmaniasis in Murine Model, Immunobiology (2018)
7. Immunization Against Cutaneous Leishmaniasis by Alginate Microspheres Loaded With Autoclaved Leishmania Major (Alm) and Quillaja Saponins, Iranian Journal of Pharmaceutical Research (2016)
8. Evaluation of Immune Response Against Leishmaniasis in Balb/C Mice Immunized With Cationic Dotap/Dope/Chol Liposomes Containing Soluble Leishmania Major Antigens, Iranian Journal of Parasitology (2019)
Experts (# of related papers)
View all Related Experts
Mahdi Mohebali (8)
Hossein Keshavarz Valian (3)
Other Related Docs
9. Development of Nano-Carriers for Leishmania Vaccine Delivery, Expert Opinion on Drug Delivery (2020)
10. The Role of Mpl and Imiquimod Adjuvants in Enhancement of Immune Response and Protection in Balb/C Mice Immunized With Soluble Leishmania Antigen (Sla) Encapsulated in Nanoliposome, Artificial Cells# Nanomedicine and Biotechnology (2018)
11. An Overview of Leishmanization Experience: A Successful Control Measure and a Tool to Evaluate Candidate Vaccines, Acta Tropica (2019)
12. Evolution of Antigen-Specific Immune Responses in Cutaneous Leishmaniasis Patients, Parasite Immunology (2021)
13. Naloxone Effects Against Cutaneous Leishmaniasis Caused by Leishmania Major Strain Mrho/Ir/75/Er in the Balb/C Mice, Infectious Disorders - Drug Targets (2023)
14. The Therapeutic Effects of Olive Leaf Extract on Leishmania Major Infection in Balb/C Mice, Marmara Pharmaceutical Journal (2017)
15. Double-Blind Randomized Efficacy Field Trial of Alum Precipitated Autoclaved Leishmania Major (Alum-Alm) Vaccine Mixed With Bcg Plus Imiquimod Vs. Placebo Control Group, Iranian Journal of Parasitology (2015)
16. A Phospholipase-A Activity in Soluble Leishmania Antigens Causes Instability of Liposomes, Current Drug Delivery (2020)
17. Comparison of Cytokine Profile of Ifn-Γ, Il-5 and Il-10 in Cutaneous Leishmaniasis Using Pbmc Vs. Whole Blood, Iranian Journal of Microbiology (2019)
18. Potential Biomarkers of Immune Protection in Human Leishmaniasis, Medical Microbiology and Immunology (2021)
19. Niosomal Formulation of Amphotericin B Alone and in Combination With Glucantime: In Vitro and in Vivo Leishmanicidal Effects, Biomedicine and Pharmacotherapy (2019)
20. Antileishmanial Activity of Urtica Dioica Extract Against Zoonotic Cutaneous Leishmaniasis, PLoS Neglected Tropical Diseases (2020)
21. Photodynamic Therapy Using Toluidine Blue O (Tbo) Dye As a Photosensitizer Against Leishmania Major, Iranian Journal of Public Health (2021)
22. Correlation Between Clinical Responses With the Drug-Susceptibility of Parasites in Iranian Cutaneous Leishmaniasis Caused by Leishmania Major, Tropical Biomedicine (2017)
23. Multi-Antigen Vaccination With Lpd Nanoparticles Containing Rgp63 and Rlmac1n Proteins Induced Effective Immune Response Against Leishmaniasis in Animal Model, Journal of Drug Delivery Science and Technology (2021)
24. Leishmania Major P27 Gene Knockout As a Novel Live Attenuated Vaccine Candidate: Protective Immunity and Efficacy Evaluation Against Cutaneous and Visceral Leishmaniasis in Balb/C Mice, Vaccine (2019)
25. Chitosan-Based Biocompatible Dressing for Treatment of Recalcitrant Lesions of Cutaneous Leishmaniasis: A Pilot Clinical Study, Indian Journal of Dermatology# Venereology and Leprology (2019)
26. Immune Response in Cutaneous Leishmaniasis Patients With Healing Vs. Non-Healing Lesions, Iranian Journal of Microbiology (2020)
27. Treatment of Resistant Visceral Leishmaniasis With Interferon Gamma in Combination With Liposomal Amphotericin B and Allopurinol, Parasitology International (2019)
28. A Novel Strategy for Enhance Potentiation of Meglumine Antimoniate Against Leishmania Major in Vitro, Iranian Journal of Parasitology (2019)
29. Engineering and Design of Promising T-Cell-Based Multi-Epitope Vaccine Candidates Against Leishmaniasis, Scientific Reports (2023)
30. Development of a New Live Attenuated Leishmania Major P27 Gene Knockout: Safety and Immunogenicity Evaluation in Balb/C Mice, Cellular Immunology (2018)
31. Vaccines for Preventing Cutaneous Leishmaniasis, Cochrane Database of Systematic Reviews (2018)
32. Post-Treatment Clinical Outcomes of Cutaneous Leishmaniosis in the Bam Area, South Eastern Iran: Analysis of Over 9,000 Cases, International Journal of Infectious Diseases (2015)
33. Effects of Combined Therapy With Silymarin and Glucantime on Leishmaniasis Induced by Leishmania Major in Balb/C Mice, Drug Research (2015)
34. Antileishmanial Activity of Allium Hirtifolium on Promastigote and Amastigote Developmental Stages of the Parasite, Leishmania Major, Medicinal Plants (2020)
35. Lived Experiences of Patients Suffering From Acute Old World Cutaneous Leishmaniasis: A Qualitative Content Analysis Study From Iran, Journal of Arthropod-Borne Diseases (2018)